Canada Post Corp Registered Pension Plan Has $6.02 Million Stock Holdings in Colgate-Palmolive Company $CL

Canada Post Corp Registered Pension Plan grew its stake in Colgate-Palmolive Company (NYSE:CL) by 36.4% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 76,130 shares of the company’s stock after buying an additional 20,308 shares during the period. Canada Post Corp Registered Pension Plan’s holdings in Colgate-Palmolive were worth $6,016,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Northwestern Mutual Wealth Management Co. increased its stake in shares of Colgate-Palmolive by 8,040.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,655,987 shares of the company’s stock valued at $380,666,000 after buying an additional 4,598,789 shares during the period. Diamond Hill Capital Management Inc. increased its position in shares of Colgate-Palmolive by 46.7% during the third quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock worth $645,719,000 after buying an additional 2,572,796 shares during the period. Amundi increased its position in shares of Colgate-Palmolive by 41.6% during the third quarter. Amundi now owns 6,294,445 shares of the company’s stock worth $487,505,000 after buying an additional 1,850,412 shares during the period. Two Sigma Investments LP increased its position in shares of Colgate-Palmolive by 360.9% during the third quarter. Two Sigma Investments LP now owns 2,126,249 shares of the company’s stock worth $169,972,000 after buying an additional 1,664,949 shares during the period. Finally, SG Americas Securities LLC increased its position in shares of Colgate-Palmolive by 3,896.0% during the fourth quarter. SG Americas Securities LLC now owns 1,189,005 shares of the company’s stock worth $93,955,000 after buying an additional 1,159,250 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Jefferies Financial Group increased their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Bank of America decreased their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research note on Friday, April 10th. UBS Group raised their price target on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Rothschild & Co Redburn set a $100.00 price target on shares of Colgate-Palmolive and gave the stock a “buy” rating in a report on Tuesday, April 21st. Finally, Wells Fargo & Company reduced their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a report on Wednesday, April 8th. Twelve equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive News Roundup

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Zacks also highlighted Colgate’s innovation strategy as a support for market share gains, with premium launches, pricing actions and science-based products helping growth in oral care and pet nutrition. Why Colgate’s Innovation Strategy Is Fueling Market Share Gains
• Neutral Sentiment: Analysts lowered near-term and longer-term EPS estimates, but the changes were relatively modest and the new forecasts still point to continued earnings growth over the next few years.
• Negative Sentiment: Zacks Research cut FY2026 EPS to $3.80 from $3.89, FY2027 to $4.01 from $4.15, FY2028 to $4.39 from $4.44, and reduced several quarterly estimates, signaling a slightly less optimistic profit outlook for Colgate-Palmolive. Analyst estimate cuts for Colgate-Palmolive

Colgate-Palmolive Stock Down 0.7%

Shares of NYSE:CL opened at $88.20 on Friday. The stock has a market cap of $70.76 billion, a price-to-earnings ratio of 34.32, a PEG ratio of 4.57 and a beta of 0.31. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The business’s 50 day moving average is $86.30 and its 200 day moving average is $84.68.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.Colgate-Palmolive’s quarterly revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.91 earnings per share. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, April 20th were given a dividend of $0.53 per share. The ex-dividend date of this dividend was Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a dividend yield of 2.4%. Colgate-Palmolive’s payout ratio is presently 82.49%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.